Five Prime IPO carries on biotech boom

Five Prime Therapeutics Inc.'s $62 million stock debut Wednesday is getting good reviews on Wall Street so far, continuing the biotech industry's rise to investment favor...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.